Stryker (SYK) Shares Outstanding (Diluted Average) (2009 - 2026)
Stryker (SYK) reported Shares Outstanding (Diluted Average) of $386.5 million for Q1 2026, little changed year-over-year from $386.4 million in Q1 2025, and little changed quarter-over-quarter from $386.5 million in Q4 2025.
Stryker (SYK) Shares Outstanding (Diluted Average) (2009 - 2026) Analysis & Trends
Stryker (SYK) has 18 years of Shares Outstanding (Diluted Average) data on file, last reported at $386.5 million in Q1 2026.
- Shares Outstanding (Diluted Average) for Q1 2026 came in at $386.5 million, changed 0.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $386.5 million (changed 0.03% YoY), and the FY2025 annual result was $386.5 million, up 8302.17% from the prior year.
- Shares Outstanding (Diluted Average) steadied at $386.5 million in Q1 2026 per SYK's latest filing, from $386.5 million in the prior quarter.
- Over five years, Shares Outstanding (Diluted Average) peaked at $386.5 million in Q4 2025 and troughed at $4.0 million in Q4 2022.
- A 5-year average of $227.9 million and a median of $382.5 million in 2022 frame the typical range for Shares Outstanding (Diluted Average).
- The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Diluted Average) surged 9492.5% in 2023, then tumbled 98.88% in 2025.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $4.0 million in 2022, then surged by 9492.5% to $383.7 million in 2023, then slumped by 98.8% to $4.6 million in 2024, then soared by 8302.17% to $386.5 million in 2025, then changed by 0.0% to $386.5 million in 2026.
- Business Quant data shows SYK's Shares Outstanding (Diluted Average) at $386.5 million in Q1 2026, $386.5 million in Q4 2025, and $4.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 386.50 Mn |
| Dec 31, 2025 | 386.50 Mn |
| Sep 30, 2025 | 4.30 Mn |
| Jun 30, 2025 | 4.20 Mn |
| Mar 31, 2025 | 386.40 Mn |
| Dec 31, 2024 | 4.60 Mn |
| Sep 30, 2024 | 385.40 Mn |
| Jun 30, 2024 | 4.40 Mn |
| Mar 31, 2024 | 4.70 Mn |
| Dec 31, 2023 | 383.70 Mn |
| Sep 30, 2023 | 384.00 Mn |
| Jun 30, 2023 | 383.60 Mn |
| Mar 31, 2023 | 383.20 Mn |
| Dec 31, 2022 | 4.00 Mn |
| Sep 30, 2022 | 381.80 Mn |
| Jun 30, 2022 | 382.50 Mn |
| Mar 31, 2022 | 5.00 Mn |
| Dec 31, 2021 | 5.30 Mn |
| Sep 30, 2021 | 5.60 Mn |
| Jun 30, 2021 | 5.40 Mn |